303 related articles for article (PubMed ID: 23131800)
1. In vitro and in vivo evaluation of an in situ gel forming system for the delivery of PEGylated octreotide.
Erfani Jabarian L; Rouini MR; Atyabi F; Foroumadi A; Nassiri SM; Dinarvand R
Eur J Pharm Sci; 2013 Jan; 48(1-2):87-96. PubMed ID: 23131800
[TBL] [Abstract][Full Text] [Related]
2. Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity.
Jones DS; Bruschi ML; de Freitas O; Gremião MP; Lara EH; Andrews GP
Int J Pharm; 2009 May; 372(1-2):49-58. PubMed ID: 19429268
[TBL] [Abstract][Full Text] [Related]
3. Development and characterisation of modified poloxamer 407 thermoresponsive depot systems containing cubosomes.
Kojarunchitt T; Hook S; Rizwan S; Rades T; Baldursdottir S
Int J Pharm; 2011 Apr; 408(1-2):20-6. PubMed ID: 21272624
[TBL] [Abstract][Full Text] [Related]
4. Modified thermoresponsive Poloxamer 407 and chitosan sol-gels as potential sustained-release vaccine delivery systems.
Kojarunchitt T; Baldursdottir S; Dong YD; Boyd BJ; Rades T; Hook S
Eur J Pharm Biopharm; 2015 Jan; 89():74-81. PubMed ID: 25481034
[TBL] [Abstract][Full Text] [Related]
5. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation.
Radivojša M; Grabnar I; Ahlin Grabnar P
Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo release of albumin using a biodegradable MPEG-PCL diblock copolymer as an in situ gel-forming carrier.
Hyun H; Kim YH; Song IB; Lee JW; Kim MS; Khang G; Park K; Lee HB
Biomacromolecules; 2007 Apr; 8(4):1093-100. PubMed ID: 17326678
[TBL] [Abstract][Full Text] [Related]
7. Biodegradable in situ gel-forming controlled drug delivery system based on thermosensitive PCL-PEG-PCL hydrogel. Part 2: sol-gel-sol transition and drug delivery behavior.
Gong C; Shi S; Wu L; Gou M; Yin Q; Guo Q; Dong P; Zhang F; Luo F; Zhao X; Wei Y; Qian Z
Acta Biomater; 2009 Nov; 5(9):3358-70. PubMed ID: 19470411
[TBL] [Abstract][Full Text] [Related]
8. Sustained release of lidocaine from Poloxamer 407 gels.
Ricci EJ; Lunardi LO; Nanclares DM; Marchetti JM
Int J Pharm; 2005 Jan; 288(2):235-44. PubMed ID: 15620863
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of an in situ gel forming system for controlled delivery of triptorelin acetate.
Abashzadeh Sh; Dinarvand R; Sharifzadeh M; Hassanzadeh G; Amini M; Atyabi F
Eur J Pharm Sci; 2011 Nov; 44(4):514-21. PubMed ID: 21946260
[TBL] [Abstract][Full Text] [Related]
10. Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels.
Yu Z; Guo F; Guo Y; Zhang Z; Wu F; Luo X
PLoS One; 2017; 12(3):e0173949. PubMed ID: 28350799
[TBL] [Abstract][Full Text] [Related]
11. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
Qian S; Wong YC; Zuo Z
Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
[TBL] [Abstract][Full Text] [Related]
12.
Hemelryck SV; Dewulf J; Niekus H; van Heerden M; Ingelse B; Holm R; Mannaert E; Langguth P
Int J Pharm X; 2019 Dec; 1():100016. PubMed ID: 31517281
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of an in situ forming gel system for sustained delivery of Florfenicol.
Yu ZG; Geng ZX; Liu TF; Jiang F
J Vet Pharmacol Ther; 2015 Jun; 38(3):271-7. PubMed ID: 25287575
[TBL] [Abstract][Full Text] [Related]
14. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
[TBL] [Abstract][Full Text] [Related]
15. Injectable block copolymer hydrogels for sustained release of a PEGylated drug.
Yu L; Chang GT; Zhang H; Ding JD
Int J Pharm; 2008 Feb; 348(1-2):95-106. PubMed ID: 17825508
[TBL] [Abstract][Full Text] [Related]
16. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
Shaheen SM; Takezoe K; Yamaura K
Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
[TBL] [Abstract][Full Text] [Related]
17. Temperature-responsive and biodegradable PVA:PVP k30:poloxamer 407 hydrogel for controlled delivery of human growth hormone (hGH).
Taheri A; Atyabi F; Dinarvnd R
J Pediatr Endocrinol Metab; 2011; 24(3-4):175-9. PubMed ID: 21648286
[TBL] [Abstract][Full Text] [Related]
18. Characterization of lung-delivered in-situ forming controlled release formulations.
Dalla-Bona AC; Stoisiek K; Oesterheld N; Schmehl T; Gessler T; Seeger W; Beck-Broichsitter M
J Pharm Pharmacol; 2015 Oct; 67(10):1349-54. PubMed ID: 25920623
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
Gupta S; Samanta MK
Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
[TBL] [Abstract][Full Text] [Related]
20. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
